Pharma

Shionogi Partners with Maze Therapeutics for MZE001’s Rights to Treat Pompe Disease

Shionogi Partners with Maze Therapeutics for MZE001’s Rights to Treat Pompe Disease

Shots: Following the completion of transaction and expiry of 30-day waiting period...

Flagship Pioneering and Metaphore Biotechnologies Partner with Novo Nordisk to Develop Therapies for Obesity

Flagship Pioneering and Metaphore Biotechnologies Partner with Novo Nordisk to Develop Therapies for Obesity

Shots: Metaphore & Flagship Pioneering have teamed up with Novo Nordisk to dev...

ARTBIO Partners with Nucleus RadioPharma to Manufacture Pb-212 Radiolabeled Therapeutic Products

ARTBIO Partners with Nucleus RadioPharma to Manufacture Pb-212 Radiolabeled Therapeutic Products

Shots: ARTBIO and Nucleus RadioPharma have entered into a strategic manufacturing...

IRLAB and McQuade Center for Strategic Research and Development (MSRD) Collaborate to Develop IRL757 for Apathy

IRLAB and McQuade Center for Strategic Research and Development (MSRD) Collaborate to Develop IRL757 for Apathy

Shots: IRLAB and MSRD (member of Otsuka Pharmaceutical) have collaborated to devel...

BioVersys Extends its Strategic Collaboration with GSK and Series C Round by CHF 12.3M

BioVersys Extends its Strategic Collaboration with GSK and Series C Round by CHF 12.3M

Shots: BioVersys and GSK have expanded their strategic collaboration to accelerate...

Astellas Collaborates with Poseida Therapeutics to Develop New Allogeneic Cell Therapies in Oncology

Astellas Collaborates with Poseida Therapeutics to Develop New Allogeneic Cell Therapies in Oncology

Shots: Astellas reported that its subsidiary, Xyphos Biosciences, & Poseida ha...

Image